Acquisition - October 27, 2025
Novartis to acquire RNA therapeutics company Avidity Biosciences
Novartis has entered into an agreement to acquire Avidity Biosciences, a San Diego-based, biopharmaceutical company focused on a new class of therapeutics enabling RNA delivery to muscle.
Global report - October 27, 2025
New platform to strengthen defence against future pandemics
The AI-powered Global Pathogen Analysis Platform aims to strengthen the pandemic preparedness globally.
Global report - October 26, 2025
Basel: Small in size – Large in life science
The northwestern corner of Switzerland offers a unique life science ecosystem, with a great mix of startups and global big pharma in close by.
Collaboration - October 21, 2025
A Nordic model for pandemic preparedness
A new Nordic research network develops models that can estimate how an infection will spread, thereby supporting rapid response during a future pandemic.
Global report - October 13, 2025
AstraZeneca in agreement with US government to lower the cost of medicines
At an event at the White House, AstraZeneca CEO Pascal Soriot joined President Trump and members of his Administration to confirm the company voluntarily met all requests set out in the President’s 31 July letter.
Global report - October 10, 2025
AstraZeneca plans to increase investment and scope of Virginia facility
AstraZeneca will invest USD 4.5 billion in its new manufacturing facility in Virginia, a proposed increase of USD 500 million to support the enhanced manufacturing capability of a broader range of medicines including cancer treatments.
